Gibson, V., Dzialo, J., Messier, T., Bzura, A., Poile, C., Rogel, J., Hahne, J. C., Habibovic, A., Stead, S., Saaman, A., Blyth, K. G., Szlosarek, P. W., Lord, S., Thistlethwaite, F., Zhang, M., Nakas, A., Wells-Jordan, P., Kutywayo, K., Butnor, K. J., Heintz, N. H., Naumov, G. N., Dungey, M., Colomina, J. H., Aktas, B., Dulloo, S., Spicer, J., Fennell, D. A., Cunniff, B. (2026). Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer. Nature Communications. https://doi.org/10.1038/s41467-026-75153-y